Helping patients find the multiple myeloma resources they deserve
How do we help multiple myeloma patients?
Massive Bio offers an independent cancer treatment analysis as well as free clinical trial matching for multiple myeloma patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.
We can also provide a comprehensive case analysis through our Virtual Tumor Board from cancer specialists. The Virtual Tumor Board (VTB) is comprised of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
Multiple Myeloma Clinical Trials
There are approximately 300 clinical trials for multiple myeloma that are currently recruiting patients in the United States right now. With such an extensive list, many of them could be beneficial for you. Our team of patient advocates, who are oncology nurses, and our artificial intelligence-based clinical trial matching system will find the best option for you.
Multiple Myeloma Facts
Multiple myeloma is a cancer of the plasma cells in the bone marrow, and there is no known cause. Normal plasma cells are an important part of the immune system, so abnormal growth can put the patient at risk for infection. In multiple myeloma, there is an overgrowth of plasma cells, which leads to low blood counts. The treatment for Multiple myeloma focuses on decreasing the severity of symptoms. Symptoms of Multiple myeloma include:
- Bone tenderness
- Bone pain
- Bone fractures
- Loss of appetite
- Kidney damage
- Nerve damage
- Skin lesions
- Enlarged tongue
- Frequent infections
- Excessive thirst
Multiple Myeloma Diagnosis
If a patient is experiencing the symptoms above, they may visit their doctor to determine what is wrong. To diagnose multiple myeloma, a bone marrow aspiration and/or biopsy is needed. Other tests that may be used to diagnose multiple myeloma include:
- Blood monoclonal immunoglobulin
- Radiology tests
These tests will also help a doctor stage the disease. Stages 1 to 3 are present in multiple myeloma. Treatment for multiple myeloma will depend on the stage and severity of symptoms present. Treatment options for multiple myeloma are drugs that control the immune system, chemotherapy, radiation therapy, stem cell transplants and surgery. Specialists such as oncologists, hematologists, radiologists, stem cell transplantation and orthopedic/spine surgeons may be involved in the treatment of multiple myeloma.
For all stages of multiple myeloma combined, the 5-year survival rate is 52%. The disease is more common in men than it is in women.
Multiple Myeloma Risk Factors
Factors that may increase risk for developing multiple myeloma include:
- Increasing age
- Male sex
- Black race
- Family history of myeloma
- Personal history of monoclonal gammopathy of undetermined significance (MGUS)
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.